Emerging Biomarkers for Early Detection of Ovarian Carcinoma: A Review

Ovarian cancer continues to be one of the most lethal gynecological malignancies globally, primarily due to its asymptomatic progression and the lack of effective early detection strategies. Most cases are diagnosed at an advanced stage when therapeutic interventions are less effective, contributing to poor survival outcomes.